Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial

PaperCitations, authors & open-access status

Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 142 citations, 2022 year and bronze oa status.

142
Citations
2022
Year
bronze
OA Status

Related on ScholarIQ

Areej El‐Jawahri
Author
Zachariah DeFilipp
Author
Blood
Journal
CAR-T cell therapy research
Topic
CAR-T cell therapy research
Topic
Integrated Circuits and Semiconductor Failure Analysis
Topic
470M+ articles · free account